JD Health's Jiangsu subsidiary has increased its registered capital by 100%, from 10 million to 20 million RMB. This expansion aims to bolster its operations in pharmaceutical retail and wholesale, as well as medical device distribution. Separately, JD Industrial announced executive changes, with Song Chunzheng resigning as CEO due to health reasons and Wang Peinuann appointed as his successor, effective July 1, 2026. AI
RANK_REASON The item reports on corporate finance and executive changes within companies that utilize AI, rather than a core AI development.
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
